Project Grant H8G48381

The Centers for Disease Control and Prevention (CDC) awarded the Oklahoma State Department of Health a $5,580,953 cooperative agreement under the Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects (CFDA 93.185) program. This funding supports public health efforts to protect people and communities from vaccine-preventable diseases by equitably increasing access, confidence, and demand for vaccines. Key goals of the project...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,635,687 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Delaware Division of Public Health. The award will support efforts to prevent and control the transmission of vaccine-preventable diseases in all ages through high and sustained immunization coverage across the lifespan in Delaware. Key objectives include increasing Vaccines for Children (VFC) program enrollment by...

The Arizona Department of Health Services (ADHS) received a $6,003,421 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) to improve public health outcomes related to vaccine-preventable diseases. The 5-year project, which began on July 1, 2025, will enhance immunization infrastructure, expand vaccine access, and strengthen data quality in Arizona. Key activities include managing vaccine procurement and...

This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...

This federal Cooperative Agreement award of $1,575,821.00 was provided by the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements (CFDA 93.268) program. The award will support the District of Columbia Department of Health (DC Health) in enhancing immunization efforts and reducing vaccine-preventable diseases across the District. Key initiatives include increasing vaccine access, promoting vaccine confidence, improving data collection and reporting,...

The Centers for Disease Control and Prevention (CDC) awarded a $3,423,334 Cooperative Agreement under the Immunization Cooperative Agreements program (CFDA 93.268) to the Maine Department of Health and Human Services (Maine DHHS). The award period is from July 1, 2025 to June 30, 2030. The purpose of the grant is to strengthen vaccine-preventable disease prevention and response efforts in Maine. Key objectives include expanding vaccine access, improving immunization rates, reducing...

This $8,640,140 Cooperative Agreement award from the Centers for Disease Control and Prevention (CFDA 93.283 - CDC Investigations and Technical Assistance) will support the Alabama Department of Public Health's Immunization Division (IMM) in strengthening vaccine-preventable disease prevention and response efforts from July 1, 2025 through June 30, 2030. The funding will enable Alabama to develop, implement, assess, and promote immunization-related activities to achieve and sustain high...

This $198,506 Cooperative Agreement awarded by the National Center for Immunization and Respiratory Diseases under the Grants to States for Medicaid (CFDA 93.778) federal grant program supports the comprehensive efforts of the Maricopa County Department of Public Health (MCDPH) to strengthen vaccine-preventable disease prevention and response within the City of Phoenix, Arizona. The key products and services to be delivered include improving vaccination coverage, increasing vaccine access for...

This Cooperative Agreement award is provided by the Centers for Disease Control and Prevention (CDC) under the Grants to States for Medicaid (CFDA 93.778) federal grant program. The $13,196,805 award to the Missouri Department of Health and Senior Services (MDHSS) aims to strengthen vaccine-preventable disease prevention and response across the state. The key objectives are to improve vaccination coverage through targeted interventions, enhance the state's immunization information systems, and...

The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...